Journal for ImmunoTherapy of Cancer (Jun 2020)

Correction: 41BB-based and CD28-based CD123-redirected T-cells ablate human normal hematopoiesis in vivo

  • Bing Huang,
  • Peiliang Wang,
  • Zhiwei Yuan,
  • Jianjian Yang,
  • Hui Xiong,
  • Ni Zhang,
  • Qi Huang,
  • Xiangning Fu

DOI
https://doi.org/10.1136/jitc-2019-000845corr1
Journal volume & issue
Vol. 8, no. 1

Abstract

Read online

No abstracts available.